-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Repligen, Lowers Price Target to $189

Benzinga·04/30/2025 16:06:50
Listen to the news
RBC Capital analyst Conor McNamara maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $202 to $189.